ELV Elevance Health, Inc.
Hospital & Medical Service Plans · NYSE · SEC CIK 1156039 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY3.6%
TTM net income YoY-7.1%
TTM EPS YoY-4.0%
Revenue 3-yr CAGR6.2%
Net income 3-yr CAGR-5.0%
Margins
Gross margin—
Operating margin2.7%
Net margin2.5%
FCF margin3.2%
EBITDA margin3.4%
Returns
ROE11.6%
ROA4.1%
ROIC (approx.)6.7%
Asset turnover1.61x
Leverage & solvency
Liabilities / assets65.0%
Debt / equity0.69x
Current ratio1.47x
Interest coverage3.76x
Cash quality & payout
Operating cash flow / net income1.48x
Accruals ratio-2.0%
Payout ratio29.2%
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B |
| Cost of revenue | $21.18B | $19.75B | $17.29B | $13.04B | $10.89B |
| SG&A expense | $20.98B | $20.02B | $20.09B | $17.70B | $15.92B |
| Operating income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B |
| Interest expense | $1.40B | $1.19B | $1.03B | $851.00M | $798.00M |
| Pretax income | $6.71B | $7.90B | $7.71B | $7.60B | $8.00B |
| Income tax | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B |
| Net income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| EBITDA | $8.74B | $9.26B | $10.24B | $9.96B | $8.86B |
| EPS (basic) | 25.28 | 25.81 | 25.38 | 24.56 | 25.26 |
| EPS (diluted) | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 |
| Dividends declared per share | — | — | 5.92 | 5.12 | 4.52 |
| Weighted avg. shares (diluted) | 224.60M | 232.90M | 237.40M | 242.80M | 246.80M |
| Balance sheet | |||||
| Cash & equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B |
| Short-term investments | $25.88B | $25.20B | $29.61B | $25.95B | $26.27B |
| Current assets | $63.00B | $58.94B | $60.03B | $55.62B | $51.12B |
| PP&E, net | $4.68B | $4.65B | $4.36B | $4.32B | $3.92B |
| Goodwill | $28.34B | $28.28B | $25.32B | $24.38B | $24.23B |
| Intangibles | $11.20B | $12.09B | $10.27B | $10.31B | $10.62B |
| Total assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B |
| Current liabilities | $41.03B | $40.58B | $41.79B | $39.70B | $34.88B |
| Short-term debt | $1.10B | $1.65B | $1.65B | $1.50B | $1.60B |
| Long-term debt | $30.80B | $29.22B | $23.25B | $22.35B | $21.16B |
| Total debt | $31.90B | $30.87B | $24.89B | $23.85B | $22.76B |
| Total liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.29B |
| Shareholders' equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.09B |
| Net debt | $22.41B | $22.58B | $18.37B | $16.46B | $17.88B |
| Shares outstanding | 220.72M | 227.48M | 233.07M | 237.96M | 241.77M |
| Cash flow statement | |||||
| Operating cash flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B |
| Capital expenditure | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B |
| Free cash flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
| Investing cash flow | -$1.34B | -$5.17B | -$5.57B | -$4.56B | -$9.64B |
| Financing cash flow | -$1.74B | $1.19B | -$3.35B | -$1.32B | $423.00M |
| Depreciation & amortization | $1.55B | $1.39B | $1.75B | $1.68B | $1.30B |
| Stock-based compensation | $276.00M | $191.00M | $289.00M | $264.00M | $255.00M |
| Dividends paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B |
| Share buybacks | $2.60B | $2.90B | $2.68B | $2.32B | $1.90B |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.